The Center for Advancing Innovation (CAI) announces the launch of the Nanotechnology Startup Challenge for Cancer (NSC2). This is the third in a series of startup challenges developed from the partnership between CAI and National Cancer Institute’s Technology Transfer Center following two award-winning competitions, the Breast Cancer Startup Challenge, and the Neuro Startup Challenge. These challenges have received some excellent recognition from Health and Human Services, the White House and were also recently written up by the Washington Post.
NSC2 is an open innovation competition designed to bring promising cancer nanotechnology inventions to market. Participating challenge teams may either select from the NIH intramural inventions or bring in an external, commercially viable, cancer-related nanotechnology invention as the basis to compete in NSC2. The NSC2 challenge architecture further amplifies the contest paradigm to move an entire scientific field forward rapidly as we are seeking to advance both NIH intramural inventions as well as extramural inventions.
Key Challenge Facts:
- Teams may enter now until Feb. 11, 2016
- A requirement to enter is the formation of a multi-disciplinary team that includes individuals with medical/scientific, legal, and business expertise, and a serial entrepreneur
- Learn valuable tools for entrepreneurship through a six-month accelerator program
- Interact with world-class mentors, advisors and judges
- Win prize money
Please support the effort: spread the word, consider startups for seed funding, nominate a judge/mentor, or join a team! Share your enthusiasm for this Challenge through Twitter – @CAIStartups. Contact us for more information at firstname.lastname@example.org or 202-438-2208.
Rosemarie Truman is Founder and CEO of The Center for Advancing Innovation whose mission is to identify breakthrough inventions and maximize their commercial potential through new entrepreneurial paradigms to make an impact on the world.
Filed under: Corporate,